We are live on ! Find out more
ITCI

Intra-Cellular Therapies Inc.
ITCI

Delisted

ITCI was delisted on the 1st of April, 2025.

Back to rankings

149 hedge funds and large institutions have $1.25B invested in Intra-Cellular Therapies Inc. in 2020 Q2 according to their latest regulatory filings, with 33 funds opening new positions, 60 increasing their positions, 32 reducing their positions, and 22 closing their positions.

New
Increased
Maintained
Reduced
Closed

121% more call options, than puts

Call options by funds: $91M | Put options by funds: $41.1M

88% more repeat investments, than reductions

Existing positions increased: 60 | Existing positions reduced: 32

66% more capital invested

Capital invested by funds: $755M → $1.25B (+$497M)

50% more funds holding in top 10

Funds holding in top 10: 2 → 3 (+1)

50% more first-time investments, than exits

New positions opened: 33 | Existing positions closed: 22

7% more funds holding

Funds holding: 139 → 149 (+10)

Holders
149
Holders Change
+10
Holders Change %
+7.19%
% of All Funds
3.06%
Holding in Top 10
3
Holding in Top 10 Change
+1
Holding in Top 10 Change %
+50%
% of All Funds
0.06%
New
33
Increased
60
Reduced
32
Closed
22
Calls
$91M
Puts
$41.1M
Net Calls
+$49.8M
Net Calls Change
+$46.6M

Top Buyers

Rank Fund Capital Flow
1
Fidelity Investments
Fidelity Investments
Massachusetts
+$15.9M
2
WA
Wasatch Advisors
Utah
+$14.7M
3
Marshall Wace
Marshall Wace
United Kingdom
+$12.8M
4
BlackRock
BlackRock
New York
+$11.5M
5
PA
Pinnacle Associates
New York
+$5.58M

Top Sellers

Rank Fund Capital Flow
1
CCM
Consonance Capital Management
New York
-$25.4M
2
T. Rowe Price Associates
T. Rowe Price Associates
Maryland
-$10.8M
3
CS
Candriam SCA
Luxembourg
-$6.54M
4
Millennium Management
Millennium Management
New York
-$5.43M
5
IC
Ikarian Capital
Texas
-$4.89M
Name Holding Trade Value Shares
Change 		Change in
Stake
Deutsche Bank
76
Deutsche Bank
Germany
$772K -$500K -24,722 -45%
BBVA
77
Banco Bilbao Vizcaya Argentaria
Spain
$770K +$607K +30,000 New
MIM
78
MetLife Investment Management
New Jersey
$679K +$64.8K +3,201 +14%
CL
79
CSS LLC
Illinois
$664K +$46.6K +2,303 +10%
AC
80
Amia Capital
United Kingdom
$657K -$91.9K -4,542 -15%
AG
81
Aperio Group
California
$624K +$13.5K +666 +3%
TD Asset Management
82
TD Asset Management
Ontario, Canada
$599K -$251K -12,400 -35%
IBT
83
International Biotechnology Trust
United Kingdom
$579K – – –
WMSA
84
Weiss Multi-Strategy Advisers
New York
$576K +$15.6K +770 +4%
Bank of Montreal
85
Bank of Montreal
Ontario, Canada
$559K +$89.7K +4,431 +24%
State Board of Administration of Florida Retirement System
86
State Board of Administration of Florida Retirement System
Florida
$551K – – –
PAM
87
Premier Asset Management
Illinois
$532K -$219K -10,840 -34%
UBS Group
88
UBS Group
Switzerland
$518K -$603K -29,794 -60%
SIM
89
Sonora Investment Management
Arizona
$517K +$408K +20,150 New
Hudson Bay Capital Management
90
Hudson Bay Capital Management
Connecticut
$513K -$2.25M -111,036 -85%
VOYA Investment Management
91
VOYA Investment Management
Georgia
$495K -$133K -6,564 -25%
HT
92
HAP Trading
New York
$494K +$389K +19,227 New
ProShare Advisors
93
ProShare Advisors
Maryland
$464K +$122K +6,006 +50%
AMC
94
Asset Management Corp
Illinois
$460K – – –
Allianz Asset Management
95
Allianz Asset Management
Germany
$454K -$368K -18,172 -51%
VEA
96
Virtus ETF Advisers
New York
$446K -$216K -10,658 -38%
M&T Bank
97
M&T Bank
New York
$439K +$109K +5,369 +46%
MLICM
98
Metropolitan Life Insurance Company (MetLife)
New York
$422K – – –
AWCI
99
Alpine Woods Capital Investors
New York
$403K -$44.5K -2,200 -12%
Principal Financial Group
100
Principal Financial Group
Iowa
$359K +$283K +13,969 New
2 3
4
5 6

ITCI Hedge Fund Activity: Q2 2020 in Review

149 of the 4,877 institutional investors tracked by Wall St. Rank reported a position in Intra-Cellular Therapies Inc. (ITCI) for Q2 2020, worth a combined $1.25B — up 66% from $755M a quarter earlier.

Buyers outnumbered sellers: 33 funds opened new ITCI positions and 22 closed out — a net gain of 11 holders — while 60 added to existing stakes and 32 trimmed.

The largest buyer was Fidelity Investments, adding an estimated $15.9M. The largest seller was Consonance Capital Management, exiting entirely with an estimated $25.4M sold.

  • 149 institutional investors held Intra-Cellular Therapies Inc. (ITCI) as of Q2 2020, up from 139 in Q1 2020.
  • Funds reported $1.25B of Intra-Cellular Therapies Inc. stock for Q2 2020, up 66% quarter-over-quarter.
  • 33 funds opened new Intra-Cellular Therapies Inc. positions in Q2 2020 and 22 closed out, a net change of +11 holders.
  • The largest Intra-Cellular Therapies Inc. buyer in Q2 2020 was Fidelity Investments, an estimated $15.9M added.
  • The largest Intra-Cellular Therapies Inc. seller in Q2 2020 was Consonance Capital Management, an estimated $25.4M sold.

Based on aggregated 13F filings for Q2 2020.